India Patent Cases
2,847 decisions indexed
Page 60 of 95 · 2,847 total
Merck Sharp & Dohme Corp. v.Metrochem Api Pvt. Ltd
The parties amicably resolved their dispute concerning Patent Infringement (CS(COMM) No. 406 of 2019). The Settlement Agreement stipulated that the suit would be decreed in favor of the Plaintiffs, who hold exclusive rights over products containing Sitagliptin.
Galatea Ltd. v.M. Kantilal Exports
This case involved multiple suits concerning patent and copyright infringement, where petitioners sought the appointment of a local commissioner to inspect infringing activities. The High Court found that the initial commission report was flawed because it did not follow mandatory provisions of the Civil Procedure Code, specifically regarding issuing notice to respondents before inspection. Consequently, the court discarded the existing reports and directed the trial court to issue a fresh commission.
BASF SE v.SEEDLINGS INDIA PRIVATE LIMITED & ANR
BASF SE filed a suit seeking permanent injunction against Seedlings India Private Limited and others for infringing its Patent No. IN 271338, which covers crystalline complexes used in fungicides/insecticides. The Plaintiff argued that the Defendants' products were approved under Section 9(4) of the Insecticides Act, despite previous undertakings by related group companies not to infringe the patent.
BASF SE v.GSP CROP SCIENCE PRIVATE LIMITED
BASF SE filed a suit seeking protection of its patent No. IN 271338, which covers crystalline complexes containing thiophanate-methyl and pyraclostrobin used as a fungicide. The court addressed several procedural applications before granting an interim order regarding the injunction request.
Unilever Plc. v.Aman Chauhan
In this interim application concerning trademark and copyright infringement, Unilever Plc. sought a short adjournment to continue identifying the true parties involved in the counterfeiting operation. The court noted that amendments had been made to implead the party found at the premises during the execution of an earlier ad-interim order. Given that Unilever was still actively tracing the ultimate owner of the infringing premises, the High Court granted the request for adjournment until May 4, 2022, ensuring the existing protective orders remained in force.
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Metrochem Api Private Limited
The Plaintiffs filed a suit seeking permanent injunction against the Defendant for infringing their patent on Lactam-Containing Compounds (Apixaban API). The Defendant submitted an affidavit stating that it had not supplied commercial quantities and agreed to manufacture/sell the drug solely under Section 107A(a) of the Patents Act, leading the Court to pass an interim restraint order.
Kanishk Sinha v.The Union Of India
The petitioner, the patentee/assignee of Patent No. 254875, challenged an order by the Secretary, Government of India, regarding their request for a patent linkage to the VAHAN e-Module. The core dispute was whether the patent holder could mandate that electric vehicle registration (specifically e-Rickshaws) be subject to NOC issuance based on the patent before official registration.
Mahindra And Mahindra Limited v.Kanishk Sinha & Ors.
The case involved a suit alleging violation of Patent Rights. The petitioner sought modification/variation of an existing ad interim injunction, citing financial losses and delay in the disposal of interlocutory applications. The court directed the lower court to ensure these pending applications are disposed of expeditiously within six weeks.
Interdigital Vc Holdings Inc v.Guangdong Oppo Mobile
The Plaintiffs filed a suit seeking a permanent injunction against the Defendants for infringing their patents related to the High Efficiency Video Encoding (HEVC/H.265) standard. The Plaintiffs also seek to add further patents and devices that may infringe during the proceedings.
Valent Biosciences Llc v.The Controller of Patents and Designs
Valent Biosciences Llc filed an appeal challenging the Assistant Controller's order rejecting its patent application (No. 201717025151). The rejection was based on a lack of inventive step under relevant sections of the Patents Act, 1970. The court allowed applications for additional documents and exempted filing fees, and listed the appeal for further hearing.
Dr Ramesh Chander Munjal & Ors. v.Dr Suraj Munjal & Ors.
The Delhi High Court addressed two connected suits, one concerning the infringement of the registered trademark 'SPECTRA EYE' and the other dealing with immovable property partition. The court noted that the trademark issue was complex and had been extensively heard by another bench. Consequently, the matter was listed for further adjudication before Hon'ble Mr. Justice Amit Bansal on May 11, 2022.
Wsou Investments Llc v.Zte Telecom India Private Limited & Anr
The Plaintiff filed a suit seeking permanent injunction against the Defendant for infringement of Indian Patent No. 322101, along with damages and other reliefs. The disputes were settled, leading to the withdrawal of the suit and counterclaim.
Elcom Innovation Pvt Ltd v.Harish Sharma & Ors.
Elcom Innovation Pvt. Ltd. filed suit seeking permanent injunction against its erstwhile employee and shareholder, Harish Sharma, alleging misuse and disclosure of proprietary sensitive and highly confidential information/data. The plaintiff sought an interim injunction to prevent further leakage of this IP. However, the court dismissed both applications, finding that the plaintiff failed to make out a prima facie case for the grant of an interim injunction due to the vagueness of the claimed confidential information.
ITC Limited v.Philip Morris Products S.A.
ITC Limited appealed against an order from the Assistant Controller of Patents and Designs which rejected a post-grant opposition against Patent No. IN319780, thereby maintaining the patent. The Appellant argued that the impugned order was non-speaking and unreasoned. Both parties consented to the matter being remanded.
Boehringer Ingelheim International GmbH & Co. KG v.Macleods Pharmaceuticals Limited
The plaintiffs sought an injunction and damages against the defendant for infringing their patent rights related to Linagliptin. The defendant challenged the plaint's validity, arguing that the suit was barred by law under Section 53(4) of the Patents Act or not properly filed. The court dismissed the application seeking rejection of the plaint.
Interdigital Technology Corporation v.Guangdong Oppo Mobile Telecommunications Corp. Ltd.
The court heard various interlocutory applications in a patent infringement suit concerning standards essential patents related to 3G, 4G, and 5G communications. The primary focus was on allowing the Plaintiffs (Interdigital) to reserve rights to add future infringing devices and additional patents from their large portfolio.
Tata Sons Pvt. Ltd. v.Akash S. Shah & Anr.
The Delhi High Court disposed of a suit filed by Tata Sons Pvt. Ltd. against Akash S. Shah & Anr., which sought permanent injunctions for trademark and copyright infringement and passing off. The parties reached an out-of-court settlement, which the court incorporated into its decree. Consequently, the suit was decreed in favor of the Plaintiff based on these terms, and the Plaintiff was granted a refund of the entire Court Fees.
ASIAN ELECTRONICS LTD. v.JUMBO ELECTRIC COMPANY
The case involves a suit for permanent injunction to restrain the infringement of patent no. 193488, which pertains to a conversion kit for fluorescent lighting. The Plaintiff has not appeared in court since November 2017, leading to the dismissal of the suit for non-prosecution.
Preeti / Kosmos Global v.Suresh R. Jain
This case involved allegations by Preeti (Kosmos Global) against Suresh R. Jain for infringing their registered copyright and passing off their hair colour products under the trademark 'BEAUTE BLANC'. The dispute centered on the defendant's use of a similar pack/carton design and the name 'Skenique'. Ultimately, both parties reached a settlement agreement, leading to the court decreeing the suit based on the terms of the joint memo.
M/s.R.K.Ganapathi Chettiar v.Kothai Dairy Farm
M/s.R.K.Ganapathi Chettiar filed a suit against Kothai Dairy Farm and others alleging infringement of their trademarks and copyrights related to the product 'ghee'. The plaintiff sought permanent injunctions, damages, and rendition of accounts due to alleged passing off and unauthorized use of artistic works and trade dress. Ultimately, the parties reached a Joint Compromise Memo on 21.03.2022, which was subsequently decreed by the Madras High Court.
Merck Sharp And Dohme Corp v.Mr. Mahaveer Chand
The contempt petition was filed by Merck Sharp And Dohme Corp alleging non-compliance with a previous court order and settlement agreement concerning patent IN' 816. The petitioner claimed that the respondent continued dealing in products covered by the patent, specifically generic versions of Sitagliptin Phosphate Monohydrate. The Court directed the respondent to file an affidavit with an unconditional apology.
Dr. Reddy's Laboratories Limited & Anr. v.The Controller Of Patents & Ors.
This judgment addressed an application seeking dismissal of a patent revocation petition on the ground that it was barred by limitation. The court examined Section 64 of the Patents Act and the concept of a 'person interested'.
Daewoong Pharmaceutical Co. Ltd. v.Controller General Of Patents Designs And Trademarks
Daewoong Pharmaceutical appealed the rejection of its Indian Patent Application (No.201817048074), which covered a crystalline form of compound c28. The rejection was based on Section 3(d) of the Patents Act, 1970, as the drug was considered known and lacked enhanced therapeutic efficacy. Daewoong sought to introduce additional data demonstrating superior properties like stability and dissolution rates. The High Court accepted the application for additional documents but framed two critical issues: whether this post-filing data is admissible, and if the crystalline form ultimately meets Section 3(d) requirements.
Torrent Pharma Limited v.Controller General Of Patents
Torrent Pharma Limited filed an appeal challenging the order dated February 1, 2021, passed by the Assistant Controller. The said order rejected the patent application for 'Use of a Thiazolo Pyrimidinone' on grounds of lack of inventive step and non-patentability under Sections 3(e) and 3(d) of the Patents Act.
SOTKON SP SLU v.WESTERN IMAGINARY TRANSCON PVT. LTD.
The case involves the alleged infringement of the Plaintiff's patent and copyright rights related to a waste management system. The Defendants are accused of infringing the Plaintiff's patent by submitting a tender for a similar waste management technology.
Pfizer Products Inc v.D Rawal
The contempt petition was filed by Pfizer Products Inc alleging non-compliance with a previous court order. The respondent submitted an affidavit stating that they had applied to the DCGI for permission to manufacture and market the new drug, Tofacitinib, under New Drugs and Clinical Trial Rules, 2019. They undertook not to commercialize the product until the patent expiry date.
Dr. Sapna Nangia v.The Assistant Controller of Patents and Designs
Dr. Sapna Nangia filed an appeal challenging the Assistant Controller of Patents and Designs' order dated January 29, 2021. The original patent application (No. 201911010599) for a device and process was rejected primarily on the ground of lacking inventive step.
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Ms Glowsun India Labs Private Limited
Bristol-Myers Squibb filed a suit seeking permanent injunction against Ms Glowsun India Labs for infringing its patent (IN 247381) related to the drug APIXABAN. The parties subsequently resolved their dispute amicably through mediation, leading to a final settlement.
Ferring B.V. v.Precise Bio Pharma Pvt. Ltd.
Ferring B.V. filed a suit alleging infringement of Patent IN 387567, which covered RTS Carbetocin for preventing post-partum haemorrhage. The Plaintiffs argued that manufacturing occurred while the patent was validly granted in February 2022. However, the court found merit in the Defendants' contention that since the grant order was subsequently set aside by a writ petition, there was no valid patent to sustain the infringement suit.
Novartis AG v.Medipol Pharmaceuticals India Pvt Ltd
Novartis AG filed a suit seeking permanent injunction against Medipol Pharmaceuticals India Pvt Ltd and Metrochem Api Private Limited for infringing its patent (No. 233161) covering 'Eltrombopag Olamine', the API in Revolade. The court found that both defendants acknowledged the validity of the patent and admitted they had not manufactured or commercially sold the patented product, leading to a decree granting permanent injunction during the patent's term.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.